HIV-1 gp41 16kDa

HIV-1 gp41 16kDa Recombinant
Cat. No.
BT20634
Source
Escherichia Coli.
Synonyms
Appearance
Sterile Filtered White lyophilized (freeze-dried) powder.
Purity
Greater than 95.0% as determined by SDS-PAGE.
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. They may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

Recombinant HIV-1 gp41 Subtype B produced in E.coli is a non-glycosylated polypeptide chain having a molecular mass of 16kDa and fused to a His tag at N-terminus.

Product Specs

Introduction
Human immunodeficiency virus (HIV) is a type of virus known as a retrovirus. It weakens the body's defense system, the immune system, making individuals vulnerable to infections and illnesses that typically wouldn't affect healthy individuals. HIV specifically targets and infects crucial immune cells, including helper T cells (particularly CD4+ T cells), macrophages, and dendritic cells. This infection results in a decline of CD4+ T cells through various mechanisms: direct destruction by the virus, accelerated cell death (apoptosis) in infected cells, and elimination of infected CD4+ T cells by CD8 cytotoxic lymphocytes that identify infected cells. When CD4+ T cell counts drop significantly, the body's ability to fight off infections becomes compromised, leading to a heightened susceptibility to opportunistic infections. HIV is categorized under the genus Lentivirus, belonging to the Retroviridae family. Lentiviruses share common characteristics in terms of their structure and biological behavior. These viruses typically cause prolonged illnesses with extended periods before symptoms appear. Transmission occurs through single-stranded, positive-sense, enveloped RNA. Upon entering a host cell, the viral RNA genome is reverse transcribed into double-stranded DNA using an enzyme called reverse transcriptase, which is carried within the virus itself. This viral DNA is then incorporated into the host cell's DNA using another virally encoded enzyme, integrase, enabling the viral genome to be transcribed. Once integrated, the virus can either remain dormant (latent) within the cell, allowing the cell to function normally, or it can become active and replicate, producing numerous viral particles that can then infect other cells.
Description
Recombinant HIV-1 gp41 Subtype B, produced in E.coli, is a non-glycosylated polypeptide chain with a molecular weight of 16kDa. It has been fused with a His tag at the N-terminus.
Physical Appearance
Sterile Filtered White lyophilized powder (freeze-dried).
Formulation
Lyophilized from a 1mg/ml solution in 20mM Na-carbonate, pH 9.6.
Solubility
It is recommended to reconstitute the lyophilized HIV-1 gp41 in sterile 18M-cm H₂O to a concentration of at least 100µg/ml. This solution can be further diluted into other aqueous solutions.
Stability
HIV-1 gp41, while stable at room temperature for 4 weeks, should be stored below -18°C. Avoid repeated freeze-thaw cycles.
Purity
Greater than 95.0% as determined by SDS-PAGE analysis.
Source
Escherichia Coli.

Product Science Overview

Introduction

The Human Immunodeficiency Virus type 1 (HIV-1) is the causative agent of Acquired Immunodeficiency Syndrome (AIDS). One of the critical components of the HIV-1 virus is the envelope glycoprotein gp41, which plays a crucial role in the virus’s ability to infect host cells. The recombinant form of this protein, particularly the 16kDa fragment, has been extensively studied for its potential applications in research and therapeutic development.

Structure and Function of gp41

The gp41 protein is a subunit of the HIV-1 envelope glycoprotein complex, which also includes gp120. Together, these proteins facilitate the virus’s entry into host cells. Gp41 is a type I transmembrane protein with a single membrane-spanning domain . It is responsible for mediating the fusion of the viral membrane with the host cell membrane, a critical step in the viral infection process.

Recombinant gp41 16kDa

The recombinant form of gp41, specifically the 16kDa fragment, is produced using various expression systems, such as Escherichia coli . This recombinant protein is often used in research to study the mechanisms of HIV-1 entry and to develop potential inhibitors that can block this process. The 16kDa fragment includes key regions of gp41 that are involved in the fusion process, making it a valuable tool for studying the protein’s function and interactions.

Applications in Research and Therapeutics

Recombinant gp41 proteins, including the 16kDa fragment, are used in various applications:

  • Vaccine Development: Researchers use recombinant gp41 to develop vaccines that can elicit an immune response against HIV-1.
  • Drug Development: The protein is used to screen for potential inhibitors that can block the fusion process, preventing the virus from entering host cells.
  • Diagnostic Tools: Recombinant gp41 is used in diagnostic assays to detect antibodies against HIV-1 in patient samples.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.